Aptevo Therapeutics Inc. cotiza a 1.72 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific…
| Periodo | 2026-05 | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-6.41 | $-40.14 | $-151.20 | $-1580.40 |
| Estimado | $-5.60 | $-37.62 | $-1497.60 | $-1515.60 |
| Sorpresa | -14.5% | -6.7% | +89.9% | -4.3% |
| Métrica | APVO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -149.4% | -40.4% | -109.0% |
| ROA | -95.5% | -32.0% | -63.5% |
| Current Ratio | 3.82 | 2.84 | +0.98 |
| Debt / Equity | — | 0.28 | — |